Real World Evidence (RWE) & Market Research
Real World Evidence and healthcare market research provide insights into how drugs, medical devices, and therapies perform in real-life clinical settings. Genelife Clinical Research supports pharmaceutical, biotechnology and medical device companies with end-to-end RWE studies and healthcare market research to enable informed decision-making across the product lifecycle.
Real World Evidence (RWE) Services
We design and execute observational and non-interventional studies using real-world data sources to generate meaningful clinical and commercial insights for pharmaceutical and medical device companies.
- Observational and Non-Interventional Studies
- Post-Marketing Surveillance Studies
- Patient Registries and Treatment Pattern Studies
- Retrospective and Prospective RWE Studies
- Comparative Effectiveness and Outcome Analysis
Healthcare Market Research
Genelife Clinical Research provides healthcare market research to support product positioning, market access, and commercialization strategies for global pharma and biotech sponsors.
Physician & KOL Studies
Physician perception studies, Key Opinion Leader (KOL) mapping, advisory board facilitation, and prescribing behavior analysis across therapeutic areas in India.
Patient Journey Analysis
In-depth patient journey mapping, treatment pattern studies, and patient-reported outcome (PRO) research to understand disease burden and unmet needs.
Product Utilization Studies
Product utilization and adoption studies, brand equity research, and market share analysis to support launch and lifecycle management decisions.
Market Access Research
Competitive landscape assessment, market sizing, pricing and reimbursement research, and commercialization strategy support for India and global markets.
Integrated RWE & Market Insights
By combining Real World Evidence with healthcare market research, Genelife provides comprehensive insights into product performance, physician prescribing behavior, patient outcomes, and market opportunities. This integrated approach supports clinical development, lifecycle management, and commercialization decisions for global sponsors working with a trusted CRO in India.
Why RWE Matters: Regulatory agencies including CDSCO, FDA, and EMA increasingly rely on RWE to complement traditional clinical trial data for drug approvals, label expansions, and post-marketing commitments — making RWE expertise an essential capability of a modern Clinical Research Organization in India.